Dernek Bahar, Kesiktas Fatma Nur
J Back Musculoskelet Rehabil. 2019;32(2):305-311. doi: 10.3233/BMR-181301.
Osteoarthritis (OA) is a chronic disease most often occurring in knee joints, leading to pain of varying severity and deterioration in daily living activities.
To compare efficacy of platelet-rich-plasma (PRP) versus PRP in combination with ozone gas injection in patients with early stage knee OA.
Retrospective data of patients who received PRP alone (n= 45) or combined treatment (PRP + ozone, n= 35) injection was analyzed. Patients were evaluated using the visual analogue scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores.
In both PRP alone and combined treatment groups, post-treatment VAS and WOMAC scores at month 1, month 3, and month 6 showed a significant reduction compared to pre-treatment scores (p< 0.001). Physical function and total WOMAC scores as well as VAS scores at post-treatment month 3 were significantly lower in the combined treatment group compared to the PRP alone group. Moreover, in the combined treatment group, VAS scores on Day 10 and hyper-inflammation at the injection site was significantly lower than the PRP alone group.
In general, similar efficacy was observed between treatment with PRP alone and treatment with PRP in combination with ozone. However, patients receiving ozone treatment are less likely to experience post-injection pain and are more likely to recover faster when compared to patients receiving PRP treatment alone.
骨关节炎(OA)是一种最常发生于膝关节的慢性疾病,会导致不同程度的疼痛以及日常生活活动能力下降。
比较富血小板血浆(PRP)与PRP联合臭氧气体注射治疗早期膝关节OA患者的疗效。
分析单独接受PRP治疗(n = 45)或联合治疗(PRP + 臭氧,n = 35)注射的患者的回顾性数据。使用视觉模拟量表(VAS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分对患者进行评估。
单独使用PRP治疗组和联合治疗组在治疗后第1个月、第3个月和第6个月的VAS和WOMAC评分与治疗前相比均显著降低(p < 0.001)。联合治疗组在治疗后第3个月的身体功能、WOMAC总分以及VAS评分均显著低于单独使用PRP治疗组。此外,联合治疗组在第10天的VAS评分和注射部位的炎症反应均显著低于单独使用PRP治疗组。
总体而言,单独使用PRP治疗与PRP联合臭氧治疗的疗效相似。然而,与单独接受PRP治疗的患者相比,接受臭氧治疗的患者注射后疼痛的可能性较小,恢复速度可能更快。